CN1251791C - 血液净化用聚砜型中空纤维膜及其制备工艺 - Google Patents
血液净化用聚砜型中空纤维膜及其制备工艺 Download PDFInfo
- Publication number
- CN1251791C CN1251791C CNB988052644A CN98805264A CN1251791C CN 1251791 C CN1251791 C CN 1251791C CN B988052644 A CNB988052644 A CN B988052644A CN 98805264 A CN98805264 A CN 98805264A CN 1251791 C CN1251791 C CN 1251791C
- Authority
- CN
- China
- Prior art keywords
- hollow
- fibre membrane
- pvp
- polysulfones type
- polysulfones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 150
- 238000000034 method Methods 0.000 title abstract description 58
- 230000008569 process Effects 0.000 title abstract description 14
- 239000012510 hollow fiber Substances 0.000 title abstract description 10
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 229920000642 polymer Polymers 0.000 claims abstract description 147
- 229920002492 poly(sulfone) Polymers 0.000 claims abstract description 110
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000002904 solvent Substances 0.000 claims abstract description 42
- 238000009987 spinning Methods 0.000 claims abstract description 32
- 238000000926 separation method Methods 0.000 claims abstract description 29
- 239000000835 fiber Substances 0.000 claims description 144
- 210000004369 blood Anatomy 0.000 claims description 71
- 239000008280 blood Substances 0.000 claims description 71
- 238000010828 elution Methods 0.000 claims description 43
- 238000000746 purification Methods 0.000 claims description 37
- 238000002360 preparation method Methods 0.000 claims description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000005516 engineering process Methods 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 235000012489 doughnuts Nutrition 0.000 claims description 11
- 150000001298 alcohols Chemical class 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 150000004040 pyrrolidinones Chemical class 0.000 claims description 3
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical group CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 claims description 2
- -1 polyethylene Polymers 0.000 claims description 2
- 238000009736 wetting Methods 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract description 117
- 238000005406 washing Methods 0.000 abstract description 10
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 9
- 230000000740 bleeding effect Effects 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 111
- 239000000243 solution Substances 0.000 description 97
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 29
- 239000007864 aqueous solution Substances 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 22
- 239000007788 liquid Substances 0.000 description 17
- 229920001477 hydrophilic polymer Polymers 0.000 description 15
- 238000005259 measurement Methods 0.000 description 15
- 238000011010 flushing procedure Methods 0.000 description 13
- 238000009792 diffusion process Methods 0.000 description 12
- 230000004888 barrier function Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 229920005989 resin Polymers 0.000 description 10
- 239000011347 resin Substances 0.000 description 10
- 238000012216 screening Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000000149 penetrating effect Effects 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000023555 blood coagulation Effects 0.000 description 5
- 238000010926 purge Methods 0.000 description 5
- 230000010148 water-pollination Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 4
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 4
- 238000004804 winding Methods 0.000 description 4
- 102000004506 Blood Proteins Human genes 0.000 description 3
- 108010017384 Blood Proteins Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 230000001112 coagulating effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000001631 haemodialysis Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 230000003760 hair shine Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 238000000045 pyrolysis gas chromatography Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 229920003072 Plasdone™ povidone Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000005260 alpha ray Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- BXKDSDJJOVIHMX-UHFFFAOYSA-N edrophonium chloride Chemical compound [Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1 BXKDSDJJOVIHMX-UHFFFAOYSA-N 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000002166 wet spinning Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/66—Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
- B01D71/68—Polysulfones; Polyethersulfones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
- B01D67/0011—Casting solutions therefor
- B01D67/00111—Polymer pretreatment in the casting solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
- B01D69/087—Details relating to the spinning process
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/12—Specific ratios of components used
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/30—Cross-linking
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- External Artificial Organs (AREA)
- Artificial Filaments (AREA)
Abstract
Description
膜体PVP含量(%) | 膜体水溶性PVP(%) | 表面PVP含量(%) | 洗提PVP(*)(mg/m2) | 撕裂结构 | 选择性分离层(μm) | 血液残留 | 强度(g/hf) | 透水性(**) | Alb筛分系数(%) | β2-Mg筛分系数(%) | |
实施例1 | 7 | 11.4 | 38 | 0.25 | 不存在 | 10.5 | 没有 | 17.1 | 210 | 0.003 | 0.64 |
实施例2 | 7.1 | 11.7 | 38 | 0.26 | 不存在 | 10.6 | 没有 | 17.2 | 205 | 0.003 | 0.64 |
实施例3 | 8.9 | 13.4 | 39 | 1.01 | 不存在 | 11.2 | 没有 | 17.1 | 175 | 0.002 | 0.55 |
实施例4 | 5 | 13.8 | 35 | 0.27 | 不存在 | 4.8 | 没有 | 19.2 | 287 | 0.004 | 0.68 |
实施例5 | 8.1 | 11.9 | 44 | 0.25 | 不存在 | 8.2 | 没有 | 16.3 | 165 | 0.004 | 0.61 |
实施例6 | 4.5 | 17.3 | 30 | 0.41 | 不存在 | 9.2 | 没有 | 19.8 | 514 | 0.005 | 0.7 |
实施例7 | 5.5 | 14.2 | 33 | 0.3 | 不存在 | 7.5 | 没有 | 19 | 222 | 0.002 | 0.68 |
实施例8 | 8 | 12 | 37 | 0.9 | 10.2 | 没有 | 17.4 | 188 | 0.002 | 0.57 | |
实施例9 | 7.2 | 11.4 | 38 | 0.28 | 10.4 | 没有 | 17.2 | 222 | 0.003 | 0.65 | |
比较例1 | 4.8 | 89.6 | 31 | 2.2 | 不存在 | 10.5 | 没有 | 17.2 | 229 | 0.003 | 0.63 |
比较例2 | 4.8 | 0.42 | 31 | 0.1 | 不存在 | 11.1 | 有 | 17.2 | 209 | 0.003 | 0.67 |
比较例3 | 7.4 | 10.8 | 37 | 0.25 | 存在 | 11.5 | 有 | 17.7 | 255 | 0.01 | 0.69 |
比较例4 | 7.3 | 11.1 | 38 | 0.28 | 不存在 | 9.2 | 没有 | 17 | 245 | 0.009 | 0.68 |
比较例5 | 3.2 | 6.3 | 24 | 0.95 | 不存在 | 6.8 | 有 | 21.2 | 702 | 0.011 | 0.85 |
比较例6 | 8.9 | 17 | 47 | -- | -- | -- | -- | 11.7 | -- | -- | -- |
比较例7 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
比较例8 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Claims (10)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP142963/1997 | 1997-05-19 | ||
JP14296397 | 1997-05-19 | ||
JP132599/98 | 1998-04-28 | ||
JP10132599A JPH11309355A (ja) | 1998-04-28 | 1998-04-28 | ポリスルホン系中空糸型血液浄化膜とその製造方法 |
JP132599/1998 | 1998-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1257434A CN1257434A (zh) | 2000-06-21 |
CN1251791C true CN1251791C (zh) | 2006-04-19 |
Family
ID=26467136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB988052644A Expired - Lifetime CN1251791C (zh) | 1997-05-19 | 1998-05-18 | 血液净化用聚砜型中空纤维膜及其制备工艺 |
Country Status (6)
Country | Link |
---|---|
US (1) | US6432309B1 (zh) |
EP (2) | EP0997182A4 (zh) |
JP (1) | JP3474205B2 (zh) |
KR (1) | KR100351886B1 (zh) |
CN (1) | CN1251791C (zh) |
WO (1) | WO1998052683A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001427A (zh) * | 2013-02-27 | 2014-08-27 | 旭化成医疗株式会社 | 血液处理用中空纤维膜、血液净化器及其制造方法 |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100804330B1 (ko) * | 1998-11-09 | 2008-02-15 | 아사히 카세이 쿠라레 메디칼 가부시키가이샤 | 혈액 정화기 |
US6322703B1 (en) * | 1999-04-20 | 2001-11-27 | Asahi Kasei Kabushiki Kaisha | Method for purifying aqueous suspension |
JP4211168B2 (ja) * | 1999-12-21 | 2009-01-21 | 東レ株式会社 | 透析器の製造方法および滅菌法 |
EP1439212B1 (en) | 2001-10-04 | 2008-01-02 | Toray Industries, Inc. | Hydrophilic material and process for producing the same |
CZ2002184A3 (cs) * | 2002-01-16 | 2003-09-17 | Eidos, S. R. O. | Mikroporézní membránová dutá vlákna s podélně proměnnými mechanickými a filtračními vlastnostmi a způsob jejich přípravy |
US6890435B2 (en) * | 2002-01-28 | 2005-05-10 | Koch Membrane Systems | Hollow fiber microfiltration membranes and a method of making these membranes |
KR100813889B1 (ko) * | 2002-08-20 | 2008-03-18 | 주식회사 코오롱 | 폴리설폰계 중공사막의 제조방법 |
US7563376B2 (en) * | 2002-09-12 | 2009-07-21 | Asahi Kasei Kuraray Medical Co., Ltd. | Plasma purification membrane and plasma purification system |
SE0203857L (sv) * | 2002-12-20 | 2004-06-21 | Gambro Lundia Ab | Permselektivt membran och förfarande för tillverkning därav |
JP3594032B1 (ja) * | 2003-08-29 | 2004-11-24 | 東洋紡績株式会社 | 高透水性中空糸膜型血液浄化器 |
TWI406703B (zh) | 2003-11-17 | 2013-09-01 | Asahi Kasei Medical Co Ltd | Purify blood with hollow fiber membrane and use its blood purifier |
JP3551971B1 (ja) | 2003-11-26 | 2004-08-11 | 東洋紡績株式会社 | ポリスルホン系選択透過性中空糸膜 |
JP3580314B1 (ja) * | 2003-12-09 | 2004-10-20 | 東洋紡績株式会社 | ポリスルホン系選択透過性中空糸膜束およびその製造方法 |
DE102004008221B4 (de) | 2004-02-19 | 2006-01-26 | Membrana Gmbh | Dialysemembran mit verbesserter Mittelmolekülentfernung |
JP3642065B1 (ja) | 2004-03-22 | 2005-04-27 | 東洋紡績株式会社 | 選択透過性分離膜および選択透過性分離膜の製造方法 |
JP3636199B1 (ja) * | 2004-03-23 | 2005-04-06 | 東洋紡績株式会社 | ポリスルホン系選択透過性中空糸膜束とその製造方法および血液浄化器 |
ITRM20040193A1 (it) * | 2004-04-19 | 2004-07-19 | Lysitech S R L | Processo per la produzione di membrane polimeriche capillari cave, utili per il trattamento del sangue e dei suoi derivati. |
CN101035576B (zh) | 2004-08-06 | 2011-01-12 | 旭化成可乐丽医疗株式会社 | 聚砜血液透析器 |
RU2369429C2 (ru) * | 2004-08-10 | 2009-10-10 | Нипро Корпорейшн | Модуль половолоконных мембран и способ его изготовления |
JP3772909B1 (ja) * | 2005-04-04 | 2006-05-10 | 東洋紡績株式会社 | 血液浄化器 |
CN101237899B (zh) * | 2005-08-10 | 2012-12-19 | 旭化成医疗株式会社 | 中空纤维膜型血液净化装置 |
US8881915B2 (en) * | 2006-04-26 | 2014-11-11 | Toyo Boseki Kabushiki Kaisha | Polymeric porous hollow fiber membrane |
KR100835655B1 (ko) | 2006-06-16 | 2008-06-09 | (주)에어레인 | 기체분리막 제조방법 및 이로부터 제조된 기체분리막 |
ES2342097T3 (es) * | 2006-07-07 | 2010-07-01 | Gambro Lundia Ab | Membrana de separacion de plasma. |
JP4582081B2 (ja) * | 2006-11-16 | 2010-11-17 | 東洋紡績株式会社 | 血液処理用の選択分離膜およびその製造方法およびモジュール |
US20080135481A1 (en) * | 2006-12-06 | 2008-06-12 | General Electric Company | Polyarylethernitrile hollow fiber membranes |
US20110168631A1 (en) * | 2006-12-15 | 2011-07-14 | General Electric Company | Methods and apparatuses for water filtration using polyarylether membranes |
US7977451B2 (en) * | 2006-12-15 | 2011-07-12 | General Electric Company | Polyarylether membranes |
US7695628B2 (en) * | 2006-12-15 | 2010-04-13 | General Electric Company | Polyarylether membranes |
US7669720B2 (en) | 2006-12-15 | 2010-03-02 | General Electric Company | Functional polyarylethers |
CN101209396B (zh) * | 2006-12-31 | 2011-07-06 | 山西金泉合成纤维制造有限公司 | 共混聚砜中空纤维膜及制备方法 |
TWI374038B (en) * | 2007-05-25 | 2012-10-11 | Asahi Kasei Medical Co Ltd | A polysulphone-based membrane for the blood treatment and its manufacturing method |
US9616393B2 (en) | 2007-12-06 | 2017-04-11 | Asahi Kasei Medical Co., Ltd. | Porous hollow fiber membrane for treating blood |
JP2009171302A (ja) * | 2008-01-17 | 2009-07-30 | Panasonic Corp | 携帯電子機器 |
US7964697B2 (en) | 2008-08-13 | 2011-06-21 | General Electric Company | Polyarylether membranes |
US7985339B2 (en) | 2008-08-25 | 2011-07-26 | General Electric Company | Polyarylether compositions bearing zwitterion functionalities |
TWI432255B (zh) * | 2008-09-26 | 2014-04-01 | Asahi Kasei Chemicals Corp | The use of porous hollow fiber membranes for the manufacture of clarified biomedical culture media |
DK2377599T3 (da) * | 2008-12-25 | 2020-12-07 | Toyo Boseki | Porøs hulfiber menbran |
JP5062773B2 (ja) * | 2009-03-31 | 2012-10-31 | 旭化成メディカル株式会社 | 血液浄化器 |
JP5226587B2 (ja) * | 2009-03-31 | 2013-07-03 | 旭化成メディカル株式会社 | 高性能血液浄化器 |
JP2010233999A (ja) * | 2009-03-31 | 2010-10-21 | Asahi Kasei Kuraray Medical Co Ltd | 血液浄化器 |
JP5371867B2 (ja) * | 2009-03-31 | 2013-12-18 | 旭化成メディカル株式会社 | 中空糸膜及びその製造方法 |
US8753515B2 (en) | 2009-12-05 | 2014-06-17 | Home Dialysis Plus, Ltd. | Dialysis system with ultrafiltration control |
US8501009B2 (en) | 2010-06-07 | 2013-08-06 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Fluid purification system |
CA2824396C (en) | 2011-02-04 | 2015-12-15 | Fresenius Medical Care Holdings, Inc. | Performance enhancing additives for fiber formation and polysulfone fibers |
AU2012318561B2 (en) | 2011-10-07 | 2017-04-20 | Outset Medical, Inc. | Heat exchange fluid purification for dialysis system |
US9956334B2 (en) | 2011-11-04 | 2018-05-01 | Asahi Kasei Medical Co., Ltd. | Separation membrane for blood processing and blood processing apparatus having the membrane installed therein |
TWI465618B (zh) * | 2011-11-15 | 2014-12-21 | Univ Chia Nan Pharm & Sciency | 可控制皮層之中空纖維膜製備方法及其滲透蒸發方法 |
EP2641653B1 (en) | 2012-03-23 | 2021-05-12 | Agfa-Gevaert Nv | Method for manufacturing solvent resistant polymeric membranes |
JP6197649B2 (ja) | 2012-09-26 | 2017-09-20 | 東レ株式会社 | 複合半透膜 |
JP6078641B2 (ja) | 2013-04-19 | 2017-02-08 | 旭化成メディカル株式会社 | 血液処理用中空糸膜及び当該血液処理用中空糸膜の製造方法 |
CN103877634B (zh) * | 2014-03-10 | 2016-06-22 | 石家庄达爱医疗器械科技有限公司 | 一种血液透析器及血液透析装置 |
EP4335539A3 (en) | 2014-03-29 | 2024-05-01 | Princeton Trade and Technology Inc. | Blood processing cartridges and systems, and methods for extracorporeal blood therapies |
EP3838308A1 (en) | 2014-04-29 | 2021-06-23 | Outset Medical, Inc. | Dialysis system and methods |
CN104307390A (zh) * | 2014-11-05 | 2015-01-28 | 华玉叶 | 复合膜 |
CN104689729B (zh) * | 2015-03-24 | 2017-01-11 | 广州市恩德氏医疗制品实业有限公司 | 聚砜族与醋酸纤维素混纺中空纤维膜液和制备方法及其制成的中空纤维膜 |
US10426884B2 (en) | 2015-06-26 | 2019-10-01 | Novaflux Inc. | Cartridges and systems for outside-in flow in membrane-based therapies |
FR3040997B1 (fr) * | 2015-09-15 | 2019-12-27 | Arkema France | Composition de solvant(s) comprenant un melange d'une molecule ayant une fonction sulfoxyde et d'une molecule ayant une fonction amide |
EP3352888B8 (en) | 2015-09-24 | 2022-01-12 | Princeton Trade and Technology Inc. | Cartridges for hollow fibre membrane-based therapies |
DE102016002440A1 (de) * | 2016-03-01 | 2017-09-07 | Fresenius Medical Care Deutschland Gmbh | Hohlfasermembran mit dreidimensionaler Lockung |
JP7025408B2 (ja) | 2016-08-19 | 2022-02-24 | アウトセット・メディカル・インコーポレイテッド | 腹膜透析システム及び方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4906375A (en) * | 1984-07-14 | 1990-03-06 | Fresenius, Ag | Asymmetrical microporous hollow fiber for hemodialysis |
DE3426331A1 (de) | 1984-07-17 | 1986-01-30 | 6380 Bad Homburg Fresenius AG | Asymmetrische mikroporoese hohlfaser fuer die haemodialyse sowie verfahren zu ihrer herstellung |
JPH0675667B2 (ja) | 1985-04-17 | 1994-09-28 | 東レ株式会社 | ポリスルホン系樹脂半透膜の製造方法 |
JPH089668B2 (ja) | 1986-10-14 | 1996-01-31 | 東レ株式会社 | 親水化膜およびその製造法 |
JPS6397205A (ja) | 1986-10-15 | 1988-04-27 | Toray Ind Inc | ポリスルホン系樹脂半透膜の処理方法 |
JP2505428B2 (ja) | 1986-10-15 | 1996-06-12 | 東レ株式会社 | 低温溶解型原液およびその製造法 |
DE4007383C2 (de) * | 1990-03-08 | 1998-10-29 | Seitz Filter Werke | Herstellung von hydrophilen Mikrofiltrationsmembranen aus Polysulfonen |
JP3097149B2 (ja) | 1991-03-28 | 2000-10-10 | 東レ株式会社 | 医療透析用モジュールおよびその製造方法 |
US5762798A (en) * | 1991-04-12 | 1998-06-09 | Minntech Corporation | Hollow fiber membranes and method of manufacture |
JPH0554373A (ja) | 1991-08-27 | 1993-03-05 | Sumitomo Metal Mining Co Ltd | 磁気記録媒体 |
EP0550798A1 (de) | 1991-10-04 | 1993-07-14 | Kawasumi Laboratories, Inc. | Hohlfasermembran auf Basis von Polysulfon |
JP3232117B2 (ja) * | 1991-11-19 | 2001-11-26 | 鐘淵化学工業株式会社 | ポリスルホン多孔質中空糸 |
JP3117575B2 (ja) | 1992-04-29 | 2000-12-18 | 株式会社クラレ | ポリスルホン系中空繊維膜とその製造方法 |
US5340480A (en) * | 1992-04-29 | 1994-08-23 | Kuraray Co., Ltd. | Polysulfone-based hollow fiber membrane and process for manufacturing the same |
US5232601A (en) * | 1992-05-29 | 1993-08-03 | W. R. Grace & Co.-Conn. | High flux hollow fiber membrane |
JPH06339620A (ja) * | 1993-11-29 | 1994-12-13 | Toray Ind Inc | ポリスルホン系樹脂半透膜の処理方法 |
JPH07289866A (ja) * | 1994-04-27 | 1995-11-07 | Asahi Medical Co Ltd | ポリスルホン系選択透過膜 |
KR100346590B1 (ko) | 1994-06-07 | 2002-09-18 | 미쯔비시 레이온 가부시끼가이샤 | 폴리술폰제다공질막및그제법 |
DE69623196T3 (de) | 1995-06-30 | 2019-11-21 | Toray Industries, Inc. | Permselektive Membranen und Verfahren zu ihrer Herstellung |
JP3617194B2 (ja) * | 1995-06-30 | 2005-02-02 | 東レ株式会社 | 選択透過性分離膜及びその製造方法 |
US5938929A (en) * | 1995-06-30 | 1999-08-17 | Toray Industries, Inc. | Polysulfone hollow fiber semipermeable membrane |
-
1998
- 1998-05-18 KR KR1019997010650A patent/KR100351886B1/ko not_active IP Right Cessation
- 1998-05-18 JP JP55022398A patent/JP3474205B2/ja not_active Expired - Lifetime
- 1998-05-18 EP EP98919641A patent/EP0997182A4/en not_active Withdrawn
- 1998-05-18 US US09/423,267 patent/US6432309B1/en not_active Expired - Lifetime
- 1998-05-18 EP EP10180217A patent/EP2255866A1/en not_active Withdrawn
- 1998-05-18 CN CNB988052644A patent/CN1251791C/zh not_active Expired - Lifetime
- 1998-05-18 WO PCT/JP1998/002181 patent/WO1998052683A1/ja active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001427A (zh) * | 2013-02-27 | 2014-08-27 | 旭化成医疗株式会社 | 血液处理用中空纤维膜、血液净化器及其制造方法 |
CN104001427B (zh) * | 2013-02-27 | 2016-11-09 | 旭化成医疗株式会社 | 血液处理用中空纤维膜、血液净化器及其制造方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2255866A1 (en) | 2010-12-01 |
EP0997182A1 (en) | 2000-05-03 |
US6432309B1 (en) | 2002-08-13 |
CN1257434A (zh) | 2000-06-21 |
KR100351886B1 (ko) | 2002-09-12 |
EP0997182A4 (en) | 2000-08-23 |
WO1998052683A1 (fr) | 1998-11-26 |
KR20010012689A (ko) | 2001-02-26 |
JP3474205B2 (ja) | 2003-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1251791C (zh) | 血液净化用聚砜型中空纤维膜及其制备工艺 | |
US9028740B2 (en) | Permselective membrane and process for manufacturing thereof | |
US8197745B1 (en) | Perm selective asymmetric hollow fibre membrane for the separation of toxic mediators from blood | |
CN1125669C (zh) | 聚砜中空纤维膜,其制法和用途 | |
JPWO2002009857A1 (ja) | 改質された中空糸膜 | |
EP0436447A1 (fr) | Membrane semi-perméable asymétrique pour le traitement des liquides biologiques | |
CN1087841A (zh) | 聚砜空芯纤维膜及其制备方法 | |
JP5857407B2 (ja) | 中空糸膜および中空糸膜の製造方法 | |
CN1921930A (zh) | 改良的除去中分子的透析膜 | |
RU2667068C2 (ru) | Пористая мембрана, модуль очистки крови, содержащий пористую мембрану, и способ получения пористой мембраны | |
CN1041173C (zh) | 具有增强传递性能的高通量中空纤维膜及其制备方法 | |
KR100424995B1 (ko) | 선택투과성 막 및 그의 제조방법 | |
JPH06238139A (ja) | ポリスルホン系半透膜およびその製造方法 | |
CN1298397C (zh) | 血液净化器 | |
JPH11309355A (ja) | ポリスルホン系中空糸型血液浄化膜とその製造方法 | |
JPH05317664A (ja) | 多孔質中空糸膜 | |
JPH0970431A (ja) | ポリスルホン系中空糸型人工腎臓の製造方法および人工腎臓 | |
JP3020016B2 (ja) | 中空糸膜 | |
JP2003275300A (ja) | 血液浄化用再生セルロース中空糸膜、その製造方法および血液浄化器 | |
JPH10243999A (ja) | ポリスルホン系血液透析膜 | |
JP4386607B2 (ja) | ポリスルホン系血液浄化膜の製造方法およびポリスルホン系血液浄化膜 | |
JP2002126473A (ja) | 中空糸膜の製造方法。 | |
JP2004248905A (ja) | 血液処理用中空糸膜 | |
JPH0523555A (ja) | 流体分離器 | |
KR20050094967A (ko) | 혈액적합성이 우수한 중공사막 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: ASAHI MEDICAL CO. Free format text: FORMER NAME OR ADDRESS: ASAHI MEDICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: Tokyo, Japan, Japan Patentee after: Asahi Medical Co. Address before: Tokyo, Japan, Japan Patentee before: Asahi Medical Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Tokyo, Japan, Japan Patentee after: Asahi Kasei Kuraray Medical Co. Address before: Tokyo, Japan, Japan Patentee before: Asahi Medical Co. |
|
ASS | Succession or assignment of patent right |
Owner name: ASAHI KASEI MEDICAL CO., LTD. Free format text: FORMER OWNER: ASAHI KASEI KURARAY MEDICAL CO., LTD. Effective date: 20120801 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120801 Address after: Tokyo, Japan Patentee after: Asahi Kasei Medical Co., Ltd. Address before: Tokyo, Japan, Japan Patentee before: Asahi Kasei Kuraray Medical Co. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060419 |